Recombinant E. coli Pathway for Glucaric Acid Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing D-glucaric acid are inefficient and costly, involving chemical oxidation of D-glucose with nitric acid, and there is a need for a biological approach that mimics the mammalian pathway but is more effective.
Innovation Solution
A novel pathway is constructed in E. coli by cloning and expressing genes encoding uronate dehydrogenase, myo-inositol oxygenase, and myo-inositol 1-phosphate synthase, enabling the production of glucaric acid from glucose through a series of enzymatic steps, significantly increasing flux and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If chemical oxidation of D-glucose with nitric acid is used to produce D-glucaric acid, then production can be achieved, but the process is nonselective and expensive
Solution Approach 1:
The patent replaces chemical oxidation with nitric acid with a biological enzymatic system consisting of myo-inositol oxygenase and uronate dehydrogenase. This substitution transforms a nonselective chemical process into a selective biological process, where enzymes specifically catalyze the conversion of glucose to glucaric acid through glucuronic acid intermediate, eliminating the need for harsh chemicals and improving both selectivity and cost-effectiveness
Solution Approach 2:
The patent changes the fundamental reaction parameters from chemical oxidation conditions (nitric acid, high temperature, nonselective) to biological enzymatic conditions (aqueous environment, mild temperature, high selectivity). By expressing recombinant enzymes in E. coli, the system operates under physiological conditions that inherently provide high substrate specificity and product selectivity, directly addressing the selectivity problem of chemical oxidation
2Productivity
If the mammalian D-glucuronic acid pathway is mimicked for biological production, then a biological approach is achieved, but the pathway consists of more than ten conversion steps making it inefficient
Solution Approach 1:
The patent extracts and utilizes only the essential terminal enzymes from the complex mammalian pathway: myo-inositol oxygenase (which produces glucuronic acid) and uronate dehydrogenase (which converts glucuronic acid to glucaric acid). By taking out these key enzymatic steps and expressing them recombinantly in E. coli, the patent eliminates the need for the preceding ten+ conversion steps, dramatically simplifying the pathway while maintaining biological production efficiency
Solution Approach 2:
The patent segments the complex mammalian pathway into discrete, expressible gene components. By cloning and expressing the ino1 gene (myo-inositol 1-phosphate synthase), miox gene (myo-inositol oxygenase), and udh gene (uronate dehydrogenase) separately and then co-expressing them in E. coli, the patent creates a modular, efficient pathway that bypasses the inefficient natural pathway while achieving high productivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This biological approach allows for high quantities of glucaric acid production, offering a more efficient and selective method compared to chemical synthesis, with potential applications in producing nylons and polyesters.
Implementation Method 1
Uronate dehydrogenase can convert glucuronic acid to glucaric acid
Implementation Method 2
A second enzyme, myo-inositol oxygenase (MIOX), converts myo-inositol to glucuronic acid
Implementation Method 3
A first enzyme, myo-inositol 1-phosphate synthase (Ino1/MIPS), produces myo-inositol from glucose, through glucose-6-phospate as an intermediate
Data Source
AI summary
The invention relates to the production of glucuronic and glucaric acid in cells through recombinant expression of myo-inositol 1-phosphate synthase, myo-inositol oxygenase and uronate dehydrogenase. Cloning and characterization of the gene encoding uronate dehydrogenase is also disclosed.